Purpose Delayed ligamentization following anterior cruciate ligament reconstruction (ACLR) may result in reduced graft stiffness and strength, and an increased risk of secondary re-tear. Remnant sparing ACLR may accelerate ligamentization and proprioceptive function, theoretically reducing re-injury risk. This study sought to investigate 10-year graft failure rates and patient perceived knee functioning in those undergoing ACLR with remnant preservation (RP), versus remnant debridement (RD). Methods A prospective RCT allocated 49 patients to ACLR with a hamstrings autograft together with a RD (n = 25) or RP (n = 24) procedure, of which 86% were clinically evaluated at 10 years (22 RD, 22 RP). A detailed chart review and patient phone consultation was undertaken with all patients at 10 years to evaluate the incidence (and timing) of subsequent re-tear and/or contralateral ACL tear, as well as other knee injuries/surgeries, the patient's ability to perform full work/sport duties and their perceived knee function using a numerical rating scale (NRS). Results No significant differences existed between groups in descriptive variables. There were 2 graft ruptures (10.0%) in the RP group and 3 (13.6%) in the RD group, with an earlier mean time to graft failure in the RD group (RD 7.7 ± 4.5 months, RP 49.5 ± 17.7 months), albeit the size of this sub-sample was too small for statistical comparison. There was a significantly higher number of patients requiring ≥ 1 additional ipsilateral knee surgery in the RP group (RP = 10, RD = 4, p = 0.048). At 10 years, there were no significant group differences in the percentage of patients returning to unrestricted activity, with 16 (72.7%) and 15 (75.0%) patients in the RD and RP ACLR groups, respectively, unrestricted in work/sport duties. There were no significant group differences in the functional NRS ratings. Conclusions No long term clinical benefit of RP ACLR could be determined by this study with similar re-tear incidence and perceived knee function. A statistically higher number of re-operations were observed in RP ACLR patients and, while re-tears were observed later after RP versus RD ACLR, the study was underpowered to detect statistical significance. Level of evidence Level II (prospective randomized controlled trial).
Introduction
Following primary anterior cruciate ligament reconstruction (ACLR), secondary ACL re-injury rates on the ipsilateral knee have been estimated at 7%, with 8% of patients also proceeding toward a contralateral ACL tear [29] . A number of causes of graft failure have been reported, including those related to abnormal mechanical loads (secondary event, chronic repetitive loads and/or inadequate rehabilitation), surgical error (non-anatomical tunnel placement or misdiagnosed associated injuries), failure of graft fixation and/or failure of graft due to graft selection, infection or inadequate graft incorporation [25] . Successful graft incorporation (and subsequent maturation and function) is dependent on the process of graft ligamentization (i.e. the biological remodeling of the new ligament) [4, 12] . Biological failure may refer to the incomplete or delayed ligamentization of the graft resulting in reduced graft stiffness and strength, and an increased risk of re-injury.
Remnant preservation (RP) ACLR aims to retain the ruptured ACL tissue and synovium within the intercondylar notch [8] . This tissue supports vascular [5, 28] and neural elements [14, 22] which may enhance graft ligamentization [3, 8, 30] , while preserving the mechanoreceptors of the native ACL remnant may improve the restoration of proprioceptive function [2, 31] , theoretically reducing the risk of graft failure. Furthermore, RP ACLR may improve the accuracy of tunnel placement [16] , reduce tunnel widening [8, 16] and improve knee stability [20, 31] . However, removing the native ACL stump may reduce the chance of arthrofibrosis [18, 24] , cyclops lesions [1] and post-operative knee extension deficits [20] , while facilitating improved visualisation and subsequent technical performance [7] . In that context, RP ACLR could lead to more frequent postoperative symptoms and/or re-operations. Overall, the topic of RP ACLR remains controversial and systematic reviews and meta-analyses would suggest similar clinical outcomes, albeit no longer term comparative studies exist [10, 17, 27] .
Previously, a randomized study published by Gohil et al. [8] demonstrated similar early clinical outcomes, though earlier ligament revascularization according to magnetic resonance imaging (MRI) assessment, in patients undergoing a minimal versus standard debridement ACLR method.
The purpose of the current study was to evaluate this patient cohort at 10 years. The hypotheses of the current study were that patients that underwent RP ACLR would: (1) perceive a better long-term functioning knee, and (2) have comparable re-operation and graft failure rates (with longer time to graft re-injury), compared with those undergoing standard debridement. As the clinical relevance, given the lack of long term studies investigating RP ACLR, as well the aforementioned theoretical advantages including enhanced graft ligamentization [3, 8, 30] , improved restoration of proprioceptive function [2, 31] , improved accuracy of tunnel placement [16] , reduced incidence of tunnel widening [8, 16] and improved knee stability [20, 31] , it is important to know whether preservation of the remnant at the time of ACLR actually provides any longer term clinical benefit to the patient.
Materials and methods
Ethics approval was provided by the relevant hospital human research ethics committee and the consent of all participants was obtained prior to review, though this study was not registered with any trial registry. This current study was a 10 year follow-up of a previously published, prospective randomized controlled trial (RCT) of patients undergoing arthroscopic ACLR utilizing a hamstrings autograft with either a RP or remnant debridement (RD) technique [8] . All reconstructions were performed between February 2004 and July 2005 by the principal investigator (PA). A flowchart of patient recruitment, early [8] and long-term (current analysis) assessment is demonstrated in Fig. 1 . The initial study recruited 49 patients (25 RD, 24 RP), though reported clinical and MRI outcomes to 12 months in 46 patients (24 RD, 22 RP). At this stage, patients were included if they were skeletally mature, consented to the study and required an isolated primary ACLR a minimum of 3 weeks from the time of their ACL tear, with or without concomitant meniscal surgery.
The cohort was randomized to one of the two operative techniques via the use of sealed envelopes opened consecutively within the operating theatre at the time of surgery [8] . Patients were randomized independent of the time since injury, and the mean time to surgery after injury was 10.4 weeks (range 6-52) in the RD group and 8.2 weeks (range 5-47) in the RP group. The current long-term follow-up includes 42 patients (86% of the original recruited sample, 22 RD and 20 RP), with 7 patients lost to follow up. Table 1 shows the demographics and concomitant surgeries of the patient sample included in the current long-term follow up (n = 42).
Operative techniques
The RD and RP ACLR techniques undertaken by this cohort have been outlined previously in detail [8] . Briefly, an arthroscopically assisted, single bundle double-loop semi-tendinosus and gracilis hamstring autologous ACLR was performed. For the RD technique, all ACL remnant tissue, ligamentum mucosa and prominent fat was removed from the intercondylar notch. The graft was placed centrally within the tibial footprint and the femoral tunnel was prepared trans-tibially. An Acuflex trans-tibial jig (Smith and Nephew) was used for tunnel placement, while the femoral tunnel was drilled free-hand. Post-operative MRI undertaken in all patients as part of this study indicated satisfactory tibial and femoral tunnel placement [8] . Femoral suspensory fixation and interference tibial fixation was performed. For the RP technique, only unstable remnant tissue was debrided, with all stable ACL remnant and notch synovium spared, as was fat pad and ligamentum mucosa. While the size of the ACL remnants were between 30-50% of the native ACL, the remnant for each patient was not specifically classified with respect to the percentage of remnant retained or the anatomical remnant attachments. The remnant was canalized with an arthroscopic shaver (4.5 mm Orbit Synovator, Smith and Nephew) to allow trans-tibial femoral preparation. The lateral notch wall debridement was restricted to a 1-2 cm 2 window for placement of the femoral tunnel. Post-operative management included early splinting (2 weeks) and weight bearing as tolerated, early range of motion exercises commencing immediately and progressive cycling and strengthening exercises from 6 to 8 weeks.
Clinical outcome measures
Initially, the medical records (clinical notes, operation records, radiology) of all patients originally recruited into the study (n = 49) were manually reviewed to determine the demographic and injury characteristics, together with details of pre-and post-operative clinical management. Following this, all patients that could be located (n = 42, 22 RD and 20 RP) were evaluated at 10 years post-surgery via a standardized phone review by an independent orthopedic registrar.
With respect to the patient review, variables collected included: (1) the incidence (and timing) of subsequent ACL re-tear and/or contralateral ACL tear, (2) the incidence (and timing) of other ipsilateral and/or contralateral knee injuries/ surgeries (whether they be related to the graft such as ACL re-tear, or not), (3) whether the patient had undergone any other second orthopaedic opinions and/or surgeries relating to their operated (or contralateral) knee, and (4) whether the patient could perform full work/sport duties. A numerical rating scale (NRS) was administered to all patients derived from the International Knee Documentation Committee (IKDC) Subjective Knee Form [11] , which asked the patient 'how would you rate the function of your knee on a scale of 0-10 (with 10 being normal, excellent function and 0 being the inability to perform any of your usual daily activities which may include sports)'. This had been previously collected to assess their pre-injury and pre-surgery (between injury and surgery) responses, and was again administered to evaluate the current perceived function (10 years postsurgery) of their knee. 
Statistical analysis
Independent samples t tests were employed to compare descriptive data and the functional NRS at each time-point, collected from the RP and RD ALCR patients retained in the 10 year analysis. Chi-square tests were used to compare categorical outcomes. Where the assumptions of the Chi-square test were not met, a Fisher's exact test was used. Statistical analysis was performed using SPSS software (SPSS, Version 23.0, SPSS Inc., USA), while statistical significance was determined at p < 0.05. The sample size for this study was originally powered to detect significant differences between the RP and RD groups in MRI-based mid-substance ACL graft signal intensity within the first 12 post-operative months [8] , with the current study evaluating the longer term 10 year clinical outcomes of the recruited cohort.
Results
There were no differences in basic descriptive variables between the RP and RD groups (Table 1) . No patient had sought opinion from another medical specialist regarding their operated knee.
At 10 year review there were 2 graft ruptures (10.0%) in the RP group (Table 2) , both of which were non-contact ACL injuries and re-injured whilst participating in the same sport (hockey = 1, Australian Rules Football = 1) where they experienced their primary ACL tear. There were 3 graft ruptures (13.6%) in the RD group (Table 2) , all of which were non-contact ACL injuries and re-injured whilst participating in the same sport (Australian Rules Football = 3) where they experienced their primary ACL tear. The RD group had earlier mean time to graft failure (7.7 ± 4.5 months) compared with the RP group (49.5 ± 17.7 months), albeit the size of this sub-sample was too small to calculate a p value (Table 2) , with 3 and 2 re-tears, respectively. The RP group demonstrated a significantly higher number of patients requiring at least one additional ipsilateral knee surgery compared with the RD group (RP = 10, RD = 4, p = 0.048), including two patients with recent loss of knee extension presumably due to a meniscal insult that was addressed at the time of the subsequent surgery, and resolved the knee extension deficit. At 10 years, there was no significant group difference in the percentage of patients returning to unrestricted activity, with 16 (72.7%) and 15 (75.0%) patients in the RD and RP ACLR groups, respectively, unrestricted in work/sport duties. There were no differences in the functional NRS ratings between groups at all pre-and postoperative (10 years) time points (Table 3) , though reported statistical power was low at 0.35.
Discussion
The most important findings from the current study were that no long term clinical benefit could be determined by using a RP surgical technique, with similar re-tear incidence (albeit a tendency toward later time to re-tear in the RP ACLR group) and perceived knee function, though a higher number of re-operations after RP ACLR. The current long-term follow-up demonstrated no difference between RP and RD ACLR in patient perceived knee function. This is similar to a number of other clinical studies, albeit the follow up of these studies only ranged from 12 to a mean 34 months post-surgery [9, 21, 23, 31] . Hong et al. [9] evaluated 80 patients (RP = 39, RD = 41) and demonstrated no clinical benefit of RP ACLR using an allograft at mean 25.7 months, while Zhang et al. [31] showed no clinical benefit of RP ACLR using a hamstring autograft at mean 24.5 months post-surgery in a study of 51 patients (RP = 27, RD = 24). Park et al. [23] also demonstrated comparable knee stability and clinical scores between 100 patients undergoing RP ACLR (n = 55) or double bundle ACLR (n = 45), at a mean 34.1 months (range 24.0-36.6 months) post-surgery. More recently, Kim et al. [13] demonstrated no difference in anterior translation, hop testing, IKDC objective grading and Lysholm scores in 185 patients that underwent ACLR using bone-patellar tendon-bone autografts at a minimum of 24 months, when stratified based on the amount of ACL remnant retained, though patients with greater than two-thirds of the preserved remnant demonstrated improved activity-related clinical outcomes (IKDC subjective grading and Tegner scores). Takahashi et al. [26] reported in a recent study of 75 patients undergoing double-bundle ACLR using a hamstring autograft, that RP ACLR may enhance graft maturation and synovial coverage, as well as knee stability. Naylor et al. [21] also demonstrated better clinical outcomes and quality of life in RP ACLR patients, though this was only an early 1 year post-operative follow-up in a matched cohort (RP = 45, RD = 45). A meta analysis by Tie et al. [27] demonstrated comparable outcomes of RP (versus RD) ACLR in knee stability, clinical/functional outcomes and the incidence of cyclops lesions, though reported that RP ACLR reduces the incidence of tibial tunnel enlargement. A systematic review by Hu et al. [10] outlined comparable, if not superior, clinical outcomes in RP ACLR, though also stated that the outcomes did not justify its use as routine clinical treatment given the absence of high quality studies with longer term follow up.
Following primary ACLR, graft failure may occur due to a number of reasons, including delayed and/or inadequate revascularization of the new tissue. Theoretically, RP ACLR may reduce the risk of failure via improved and/or accelerated graft ligamentization and proprioceptive capacity. The current study could not demonstrate any difference in graft failure rates over the 10 year period between the RP (2 patients) and the RD (3 patients) ACLR groups, with all 5 patients re-rupturing their ACL during non-contact injuries when participating (playing or training) in the sport in which they experienced their primary ACL tear. While the small patient sample is acknowledged, the current study was initially powered for early MRI analysis of the graft only [8] . Interestingly, despite the current literature that exists investigating RP ACLR, none report comparative graft failure rates. Long-term follow-up in an adequately powered RCT is needed to assess the true effect of a RP ACLR technique on early and late stage graft failure.
Regarding the timing of ACL re-injury, a number of factors may contribute to this, but early graft failure may represent a biological cause due to delayed (or inadequate) graft incorporation. RP ACLR techniques are thought to preserve vascular [5, 28] and neural elements [14, 22] in the native stump, as well as mechanoreceptors which may aid in the restoration of proprioceptive function [2, 31] . While the sample was again too small to statistically analyze, there appeared a tendency toward earlier graft failure in the RD Table 3 Numerical rating scale (NRS) measures of knee function for the two groups pre-injury, pre-surgery (between injury and surgery) and at 10 years post-surgery group, which may partly support the notion of earlier (and better quality) graft incorporation with RP ACLR, reflecting a stronger construct. Gohil et al. [8] demonstrated more vascularized grafts at 2 and 6 months post-surgery as part of the original RCT of this study cohort, evaluated via MRI using the Signal Noise Quotient (SNQ). In a comparative study, Ahn et al. 1 demonstrated larger ACL grafts in RP patients at 6 months via MRI, though there were no differences in MRI graft incorporation measures (SNQ) between RP and RD patients. While no clinical scores were reported by Ahn et al. [3] Muneta et al. [20] demonstrated that the degree of remnant volume when performing RP ACLR using a hamstring autograft may be associated with post-operative outcomes including knee stability and perceived recovery. Animal studies generally support earlier ligamentization. Wu et al. [30] demonstrated improved graft ligamentization and strength in RP ACLR (versus RD) in a rabbit model from 6 to 24 weeks post-operatively, while Mifune et al. [19] demonstrated improved cellularity and angiogenesis, together with a higher load to failure, in RP grafts at 2 and 8 weeks post-operatively in a rat study.
While it has been suggested that removing the native ACL stump (i.e. RD ACLR) may reduce the chance of arthrofibrosis [18, 24] , cyclops lesions [1] and post-operative knee extension deficits [20] , we were still surprised to observe that the RP ACLR group had a higher re-operation rate. This is a new finding and may reflect the longer follow-up in this study. The RP technique in this study preserved the fat pad and ligamentum mucosa, while inserting the graft within the remnant. By leaving these structures, anteriorly subluxed remnant tissue may not be visualized or removed, while the spared remnant tissue could potentially irritate the joint causing knee symptoms requiring re-operation. Despite this, the earlier published results for this RCT showed no group differences (RP versus RD) in the incidence of cyclops lesions, loss of knee extension or subjective outcome scores [8] . Ahn et al. [3] reported a higher incidence of cyclops lesions in RP ACLR patients at 2 years post-surgery, despite no difference in loss of knee extension. Muneta et al. [20] performed a retrospective comparative study on double bundle ACLR dividing patients into three groups based on arthroscopically assessed remnant volume. At 2 years postsurgery, the well-preserved remnant volume group had better stability but more loss of knee extension, while the moderate preserved group had the best subjective results, suggesting that more remnant volume may lessen clinical outcome. Regardless, the current study results would suggest that the increased post-operative knee problems (requiring surgical intervention) in the RP group were independent of cyclops lesions and loss of knee extension (which in the two RP cases were concomitant with a new meniscal insult and resolved following meniscal surgery), though the study outcomes have also changed the author's clinical practice. This includes removal of the ligamentum mucosa, any protruding fat pad and any unstable or impinging notch tissue, as well as viewing the remnant at 30° of knee flexion to remove any anteriorly subluxed remnant tissue. Furthermore, the current study employed a trans-tibial technique for preparing the femoral tunnel. While early post-operative MRI demonstrated satisfactory tunnel positions in all patients, the authors now advocate and employ the trans-portal technique to optimize femoral tunnel position accuracy, while an infero-medial accessory lateral portal is employed to prepare the tunnel and assist in sparing the remnant.
This study represents the first 10-year follow-up of an RCT comparing RP and RD ACLR. However, we acknowledge a range of limitations. First, while a single surgeon study may introduce some level of perceived bias, this may also be considered a strength in an attempt to standardize all other elements of the pre-, intra-and post-operative environment between the two groups being compared. Second, the time from injury to surgery may affect proprioception after ACLR, with Denti et al. [6] demonstrating that morphologically normal mechanoreceptors were present at 3 months after ACL injury, though by 9 months only a few nerve endings were present. The current study failed to exclude patients with an injury to surgery timeframe beyond 3 months and, while the mean time from injury to surgery was 10.4 and 8.2 weeks in the RD and RP groups, respectively, the longest individual timeframe was 52 weeks in the RD group and 47 weeks in the RP group (albeit there were only two patients in each group that underwent surgery beyond three months from their time of injury). Furthermore, while the size of the ACL remnants were generally between 30-50% of the native ACL, this study did not specifically quantify the size, volume or morphology of the remnant at the time of surgery. While Hong et al. [9] demonstrated no difference in proprioceptive capacity when comparing RP and RD ACLR, a study be Lee et al. [15] demonstrated a significantly better threshold to detect passive motion and reproduce passive positioning in patients with > 20% RP versus patients with < 20%. Following from this, it may therefore be important in future studies investigating RP ACLR to more accurately measure knee proprioception and better define the size, morphology and/or volume of the remnant, which were not assessed in the current study. Third, over the 10 year period 14% of patients were lost to follow-up, and those retained were only evaluated with subjective clinical review, without evaluation of functional and/or proprioceptive capacity. Finally, the current study was originally powered to observe differences in MRI graft signal in the earlier post-operative stages [8] , and the limited number of patients meant that this longer term follow up was clearly underpowered to detect the important question of differences in graft rupture rates.
As the clinical relevance, this study has demonstrated no long term clinical benefit of RP ACLR with respect to the incidence of ACL re-tear and patient-perceived knee function, despite the proposed theoretical advantages including enhanced graft ligamentization [3, 8, 30] , improved restoration of proprioceptive function [2, 31] , improved accuracy of tunnel placement [16] and reduced incidence of tunnel widening [8, 16] , as well as improved knee stability [20, 31] .
Conclusion
While this later stage clinical review was statistically underpowered, our hypotheses were generally not supported. Firstly, there was no difference between patients undergoing remnant preserved or remnant debrided ACLR in their perceived knee function. Secondly, while re-tear rates were similar across the two groups and re-tears were observed earlier after remnant debrided ACLR (albeit underpowered to statistically compare), the remnant preserved group did require significantly more secondary knee operations which was unexpected. No long term clinical benefit of remnant preserved ACLR could be determined by this study.
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